Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel metal-free catalyst technology enabling high-purity chiral secondary amines with significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111233829A details a mild asymmetric reduction method for high-purity nicotine, offering significant cost reduction in fine chemical manufacturing and scalable supply chain solutions.
Patent CN107162893A details Ru-catalyzed asymmetric hydrogenation for high-purity (R)-3-HB. Offers cost reduction in pharma manufacturing and scalable supply chain solutions.
Patent CN101796050B details a ruthenium-catalyzed asymmetric hydrogenation route for high-purity 3-quinuclidinol derivatives, offering significant supply chain and cost advantages.
Patent CN119306599A details a high-yield asymmetric hydrogenation route for Vaborbactam intermediates, offering significant cost reduction and supply chain reliability for global pharma manufacturers.
Novel patent CN103012240B enables scalable atorvastatin calcium production with improved safety and cost efficiency for global pharmaceutical supply chains.
Advanced organocatalytic route for D-Citronellal production. Patent CN103724170A analysis reveals cost-effective, metal-free manufacturing for global supply chains.
Patent CN102417523A reveals novel nitrogen heterocyclic ligands enabling high-selectivity asymmetric hydrogenation of hindered ketones for cost-effective pharmaceutical manufacturing.
Patent CN106905124A reveals high-ee asymmetric hydrogenation for citronellal. Reduces costs and improves supply chain reliability for fine chemical manufacturing.
Patent CN102381988B reveals a high-efficiency route for Rivastigmine intermediates using Ru-catalyzed asymmetric hydrogenation, offering superior purity and cost reduction.
Patent CN101910101A reveals a novel aliphatic hydrocarbon recrystallization method boosting optical purity to >99% ee for pharmaceutical intermediates efficiently.
Patent CN104725173A reveals a novel Rhodium-catalyzed asymmetric hydrogenation method for high-purity optically active aldehydes, offering significant cost reduction and supply chain reliability for fragrance manufacturers.
Patent CN109928995A introduces high-efficiency chiral ligands for carbonyl hydrogenation. Achieve superior enantioselectivity and scalable catalyst production for pharmaceutical manufacturing.
Patent CN103087105A discloses novel chiral phosphine ligands enabling high-efficiency asymmetric hydrogenation of beta-aryl enamides with exceptional enantioselectivity.
Novel N-monosulfonated chiral diamines enable efficient aqueous phase asymmetric hydrogenation, reducing solvent waste and costs for API intermediates.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Novel patent CN119504764B offers high-yield Omarigliptin synthesis. Enhances supply chain reliability and reduces manufacturing costs for diabetes API intermediates.
Patent CN109824579A details high-ee asymmetric hydrogenation. Achieve cost reduction in API manufacturing with scalable chiral alcohol production.
Patented route for high-purity Rivastigmine intermediates using Ru-catalysis. Reduces cost and improves scalability for API manufacturing.
Patent CN107445999A enables high-purity chiral cyclic amines via Rhodium catalysis. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable technology.